An in-depth look to MYCENAX BIOTECH INC. operating, investing, and financing activities

4726 free cash flow for Q3 24 is -52.81 M TWD. For 2023, 4726 free cash flow was -411.24 M TWD and operating cash flow was -115.61 M TWD.